• Explore /
  • Poster
  • / Axitinib treatment among patients with mRCC in a U.S. community oncology setting: A retrospective study of 135 patients.

Axitinib treatment among patients with mRCC in a U.S. community oncology setting: A retrospective study of 135 patients.

Abstract Poster

Authors

Thomas Hutson

Thomas Hutson

Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas, TX

Thomas Hutson , Xiaolong Jiao , Thomas Wilson , Laura A. Cisar , Elizabeth A. MacLean

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 569)

DOI

10.1200/jco.2016.34.2_suppl.569

Abstract #

569

Poster Bd #

G8

Abstract Disclosures

Similar Posters

First Author: Pengxiang Li

Poster

2015 Genitourinary Cancers Symposium

Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.

Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.

First Author: Daniel Yick Chin Heng

First Author: Lothar Mueller

First Author: Sumanta Kumar Pal